Strength Training With Eccentric Arm-cranking (KREHA)

August 23, 2022 updated by: Swiss Paraplegic Centre Nottwil
The new training device, the eccentric arm-crank, will be examined for its training effect by this project. That the training device can be used in athletes and patients with paraplegia in the future, the so-called "testing of the applicability of this concept" will be carried out during this study. Fourteen volunteer, healthy and trained people are first tested for their upper body performance, followed by a training phase over 20 trainings and at the and the performance data is collected again. The training intensity and duration is continuously increased during the training phase.

Study Overview

Status

Completed

Conditions

Detailed Description

At the beginning, the study design includes an familiarisation appointment with performance tests and training on the eccentric arm-crank device (KREHA). At least one week later, the first test sequence including a maximum strength test (bench press), magnetic resonance imaging (MRI) to determine the muscle cross-section area of the upper arm and a test to determine the anaerobic performance (Wingate test) is conducted. The second test sequence takes place one to three days later. This includes a handgrip strength test, an aerobic endurance test (ramp test on the arm crank ergometer with ergospirometry) and a further familiarisation training on the KREHA. The training phase starts within two weeks after the pre-tests have been completed. There are two to a maximum of three trainings per week. These take 30 to 60 minutes and take place on the KREHA device under the supervision of the study staff. The training phase lasts a maximum of twelve weeks (20 training sessions). The first test sequence is repeated five to eight days after the last workout. The second test sequence takes place at the same time interval as in the pre-tests.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lucerne
      • Nottwil, Lucerne, Switzerland, 6207
        • Swiss Paraplegic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • male or female
  • age between 18 and 50 years
  • experience in strength training
  • trained (minimum two times a week)
  • healthy
  • adequately informed and confirmed per signature

Exclusion Criteria:

  • findings during anamnesis of study doctor
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Eccentric Training
This Group will train on the KREHA for 20 Trainings
Over the twenty training sessions, able-bodied participants will exercise on the KREHA device. An arm-crank has to be decelerated, which will be rotated by a prematurely defined revolution rate and training duration. During this intervention a certain power has to be applied. During the whole time of training a continous progression in power and training duration is applied

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper body Performance
Time Frame: through study completion, an average of 20 weeks
Peak Power - maximal reached power, generated during the 30sec Wingate arm-crank test
through study completion, an average of 20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endurance Oxygen consumption
Time Frame: through study completion, an average of 20 weeks
VO2peak [ml/min/kg] - Basic Endurance test (Ergospirometry, arm-crank)
through study completion, an average of 20 weeks
Endurance Power
Time Frame: through study completion, an average of 20 weeks
Wmax [W] - Basic Endurance test (Ergospirometry, arm-crank)
through study completion, an average of 20 weeks
Upper body Mean Power
Time Frame: through study completion, an average of 20 weeks
Mean Power [W] - Wingate Test (arm-crank)
through study completion, an average of 20 weeks
Upper body Power - Time to Peak
Time Frame: through study completion, an average of 20 weeks
Time to Peak [s] - Wingate Test (arm-crank)
through study completion, an average of 20 weeks
Upper body Fatigue resistance
Time Frame: through study completion, an average of 20 weeks
Fatigue Index [%]- Wingate Test (arm-crank)
through study completion, an average of 20 weeks
Upper body Fatigue resistance
Time Frame: through study completion, an average of 20 weeks
Fatigue Slope [W/s] - Wingate Test (arm-crank)
through study completion, an average of 20 weeks
1RM bench press
Time Frame: through study completion, an average of 20 weeks
One Repetition Maximum (1RM) [kg]- bench press
through study completion, an average of 20 weeks
Grip Strength
Time Frame: through study completion, an average of 20 weeks
Maximal Force that can be generated by pressing hand towards a fist [N]
through study completion, an average of 20 weeks
Cross sectional muscle area
Time Frame: through study completion, an average of 20 weeks
Cross sectional area of the upper arm is measured with MRI
through study completion, an average of 20 weeks
Upper Arm Circumference
Time Frame: through study completion, an average of 20 weeks
Circumference of the upper arm is measured with measuring tape
through study completion, an average of 20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

February 15, 2022

Study Completion (Actual)

March 1, 2022

Study Registration Dates

First Submitted

November 8, 2021

First Submitted That Met QC Criteria

December 1, 2021

First Posted (Actual)

December 14, 2021

Study Record Updates

Last Update Posted (Actual)

August 24, 2022

Last Update Submitted That Met QC Criteria

August 23, 2022

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020-26 (DSR)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Strength Training

Clinical Trials on eccentric arm-cranking training

Subscribe